Gregory H Reaman

Challenges with Novel Clinical Trial Designs: Master Protocols

Michael Cecchini, Hildy Dillon, P. LoRusso, 2019, Clinical Cancer Research.

Declining childhood and adolescent cancer mortality

S. Altekruse, P. Adamson, G. Reaman, 2014, Cancer.

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors

H. Friedman, M. Bernstein, G. Reaman, 2007, Cancer.

Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia.

Kajia Cao, Mondira Kundu, Li-San Wang, 2013, Blood.

Progress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology Group.

James R. Anderson, G. Reaman, M. O'Leary, 2008, Seminars in oncology.

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

Kevin K Dobbin, Edward J Bedrick, Walker Wharton, 2010, Blood.

Childhood Cancer Research Network: a North American Pediatric Cancer Registry

G. Reaman, J. Ross, J. Steele, 2006, Cancer Epidemiology Biomarkers & Prevention.

Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.

Cheng Cheng, Dario Campana, Paul Scheet, 2012, Blood.

Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries.

Rob Pieters, Eva Steliarova-Foucher, Kathy Pritchard-Jones, 2013, The Lancet. Oncology.

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.

Xiaomin Lu, Xiaomin Lu, S. Hunger, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.